Market Closed - Nasdaq Stockholm 10:54:20 2024-04-26 EDT 5-day change 1st Jan Change
196.5 SEK +2.34% Intraday chart for Stille AB +8.86% +30.13%

Financials

Sales 2024 * 564M 51.81M 70.69M Sales 2025 * 638M 58.55M 79.89M Capitalization 1.77B 162M 221M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 3.06 x
Net cash position 2024 * 40M 3.67M 5.01M Net cash position 2025 * - 0 0 EV / Sales 2025 * 2.77 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees 106
Yield 2024 *
-
Yield 2025 *
-
Free-Float 95.33%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.34%
1 week+8.86%
Current month+9.17%
1 month+9.17%
3 months+33.67%
6 months+85.38%
Current year+30.13%
More quotes
1 week
179.50
Extreme 179.5
204.00
1 month
174.50
Extreme 174.5
204.00
Current year
142.50
Extreme 142.5
204.00
1 year
94.20
Extreme 94.2
204.00
3 years
94.20
Extreme 94.2
204.00
5 years
70.00
Extreme 70
204.00
10 years
8.45
Extreme 8.45
204.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 47 23-03-19
Director of Finance/CFO 50 20-05-31
Sales & Marketing - -
Members of the board TitleAgeSince
Director/Board Member 64 99-12-31
Director/Board Member 61 20-12-31
Chairman 52 19-12-31
More insiders
Date Price Change Volume
24-04-26 196.5 +2.34% 5,967
24-04-25 192 +0.79% 24,343
24-04-24 190.5 +3.53% 12,160
24-04-23 184 +0.82% 13,699
24-04-22 182.5 +1.11% 1,544

Delayed Quote Nasdaq Stockholm, April 26, 2024 at 10:54 am

More quotes
Stille AB is a Sweden-based company engaged in the development, manufacture, and marketing of technical medical equipment. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.
Calendar
More about the company

Quarterly revenue - Rate of surprise